PDE1A Antibodies

Santa Cruz Biotechnology provides a broad selection of PDE1A monoclonal antibodies for investigating phosphodiesterase 1A in biological processes. PDE1A monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PDE1A is an essential enzyme that regulates intracellular levels of cyclic nucleotides, specifically cAMP and cGMP, which are critical for numerous signaling pathways. By modulating these pathways, PDE1A plays a significant role in processes such as cardiac function, neuronal signaling, and smooth muscle contraction. Understanding PDE1A function is crucial for revealing its involvement in various diseases, including cardiovascular disorders and neurological conditions. PDE1A monoclonal antibodies enable precise detection and quantification of PDE1A expression levels across different tissue types. Researchers can utilize PDE1A monoclonal antibodies to examine protein localization, interactions, and modifications in cellular pathways. Advanced research techniques incorporating PDE1A monoclonal antibodies help unlock new insights into disease mechanisms and potential therapeutic targets. Santa Cruz Biotechnology monoclonal antibodies support scientific advancement by providing reliable tools for exploring PDE1A's role in health and disease.